Sponsored by
The FDA has told the Novocure company that they will review the application for approval of the Novo-TTF-100A device for recurrent glioblastoma, based on the results of the recent trial.
I am hoping to be one of the patient representatives at the FDA meeting. I need your help. I want to present a petition with a lot of names to the committee.
I set up a web page where there is information on the device, then a way for you to easily write a letter to the committee. You submit it to me online, and I will present it to them. I need you to also agree that I can speak for you at the committee meeting. We did this for the avastin meeting and I was told that it made a big difference in their decision. Last time we only had a few weeks notice and only managed 1,000 letters. I want to do much more than that this time.
Details on the treatment are on the page above the petition. To participate: go to http://www.virtualtrials.com/activism.cfm scroll down and fill out and submit the form. That will take you to a customized letter that you can either submit or you can edit then submit. No need to print out anything. All online. Should take 3 minutes or less.
Please pass this on to your friends and relatives.
Al Musella, DPM
Musella Foundation